Published in Breast Cancer Res Treat on April 14, 2015
Prognostic roles for fibroblast growth factor receptor family members in malignant peripheral nerve sheath tumor. Oncotarget (2016) 0.82
ADAM12 expression predicts clinical outcome in estrogen receptor-positive breast cancer. Int J Clin Exp Pathol (2015) 0.77
Fibroblast growth factor receptor-1 protein expression is associated with prognosis in estrogen receptor-positive/human epidermal growth factor receptor-2-negative primary breast cancer. Cancer Sci (2016) 0.77
FGFR1 is an adverse outcome indicator for luminal A breast cancers. Oncotarget (2016) 0.76
Genome-wide copy number aberrations and HER2 and FGFR1 alterations in primary breast cancer by molecular inversion probe microarray. Oncotarget (2017) 0.75
Different clinical significance of FGFR1-4 expression between diffuse-type and intestinal-type gastric cancer. World J Surg Oncol (2017) 0.75
An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma. Cancer Cell (2011) 2.78
Digital pathology: exploring its applications in diagnostic surgical pathology practice. Pathology (2010) 2.05
Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma. J Hepatol (2008) 1.87
Identification of circulating microRNA signatures for breast cancer detection. Clin Cancer Res (2013) 1.67
A molecular classification of papillary renal cell carcinoma. Cancer Res (2005) 1.60
Genomic structure of human OKL38 gene and its differential expression in kidney carcinogenesis. J Biol Chem (2003) 1.58
Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis. BMC Gastroenterol (2003) 1.55
Comparison of the UCLA Integrated Staging System and the Leibovich score in survival prediction for patients with nonmetastatic clear cell renal cell carcinoma. Urology (2010) 1.52
Conservation of breast cancer molecular subtypes and transcriptional patterns of tumor progression across distinct ethnic populations. Clin Cancer Res (2004) 1.44
Diagnostic issues in second opinion consultations in prostate pathology. Pathology (2010) 1.42
A rare case of localised AA-type amyloidosis of the ureter with spheroids of amyloid. Singapore Med J (2012) 1.39
Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins. J Clin Pathol (2011) 1.38
Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer. Mod Pathol (2009) 1.32
Hormone receptor and c-ERBB2 status in distant metastatic and locally recurrent breast cancer. Pathologic correlations and clinical significance. Am J Clin Pathol (2010) 1.29
Do primary mammary osteosarcoma and chondrosarcoma exist? A review of a large multi-institutional series of malignant matrix-producing breast tumours. Breast (2012) 1.27
Triple negative breast cancer: outcome correlation with immunohistochemical detection of basal markers. Am J Surg Pathol (2010) 1.25
Development of a next-generation sequencing method for BRCA mutation screening: a comparison between a high-throughput and a benchtop platform. J Mol Diagn (2012) 1.21
Solid pseudopapillary tumour of the pancreas. ANZ J Surg (2003) 1.19
Loss of viability during freeze-thaw of intact and adherent human embryonic stem cells with conventional slow-cooling protocols is predominantly due to apoptosis rather than cellular necrosis. J Biomed Sci (2005) 1.17
Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients. Am J Surg Pathol (2014) 1.11
The pathology of dengue hemorrhagic fever. Semin Diagn Pathol (2007) 1.10
Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma. BMC Cancer (2010) 1.08
Recurrent phyllodes tumours of the breast: pathological features and clinical implications. ANZ J Surg (2006) 1.06
Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer. Breast Cancer Res Treat (2012) 1.06
Antiinflammatory effects of genistein, a tyrosine kinase inhibitor, on a guinea pig model of asthma. Am J Respir Crit Care Med (2002) 1.05
Utility of mammaglobin and gross cystic disease fluid protein-15 (GCDFP-15) in confirming a breast origin for recurrent tumors. Breast (2010) 1.04
Spindle cell lesions of the breast--the pathologic differential diagnosis. Breast Cancer Res Treat (2007) 1.03
A molecular signature of the Nottingham prognostic index in breast cancer. Cancer Res (2004) 1.01
c-erbB-2 (HER-2/neu) immunohistochemistry in invasive breast cancer: is there concordance between standard sections and tissue microarrays? Pathology (2006) 1.01
The Karakiewicz nomogram is the most useful clinical predictor for survival outcomes in patients with localized renal cell carcinoma. Cancer (2011) 1.00
p53-Independent regulation of p21Waf1/Cip1 expression and senescence by PRMT6. Nucleic Acids Res (2012) 0.99
Global evolutionary trend of the prevalence of primary glomerulonephritis over the past three decades. Nephron Clin Pract (2010) 0.99
DEAD-box helicase DP103 defines metastatic potential of human breast cancers. J Clin Invest (2014) 0.97
Sclerosing polycystic adenosis of the parotid gland: report of a bifocal, paucicystic variant with ductal carcinoma in situ and pronounced stromal distortion mimicking invasive carcinoma. Head Neck Pathol (2011) 0.97
Mixed epithelial and stromal tumour (MEST) of the kidney: a clinicopathological report of three cases. Pathology (2009) 0.96
TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep). Clin Cancer Res (2012) 0.95
Lactobacillus species is more cytotoxic to human bladder cancer cells than Mycobacterium Bovis (bacillus Calmette-Guerin). J Urol (2002) 0.94
Is triple immunostaining with 34betaE12, p63, and racemase in prostate cancer advantageous? A tissue microarray study. Am J Clin Pathol (2007) 0.94
Clinicopathological significance of calreticulin in breast invasive ductal carcinoma. Mod Pathol (2010) 0.94
Insulin growth factor receptor-1 expression and loss of PTEN protein predict early recurrence in triple-negative breast cancer. Histopathology (2012) 0.94
Atypia in inverted urothelial papillomas: pathology and prognostic significance. Hum Pathol (2004) 0.93
Ablation of dihydroceramide desaturase 1, a therapeutic target for the treatment of metabolic diseases, simultaneously stimulates anabolic and catabolic signaling. Mol Cell Biol (2013) 0.93
Sarcomatoid renal cell carcinoma metastatic to the breast: report of a case with diagnosis on fine needle aspiration cytology. Acta Cytol (2007) 0.93
Role of IGF system of mitogens in the induction of fibroblast proliferation by keloid-derived keratinocytes in vitro. Am J Physiol Cell Physiol (2002) 0.93
Predictors of phyllodes tumours on core biopsy specimens of fibroepithelial neoplasms. Histopathology (2010) 0.93
Androgen receptor expression shows distinctive significance in ER positive and negative breast cancers. Ann Surg Oncol (2014) 0.91
Targets of genome copy number reduction in primary breast cancers identified by integrative genomics. Genes Chromosomes Cancer (2007) 0.91
Lactobacillus rhamnosus GG induces tumor regression in mice bearing orthotopic bladder tumors. Cancer Sci (2009) 0.91
TRARESA: a tissue microarray-based hospital system for biomarker validation and discovery. Pathology (2008) 0.91
Flat epithelial atypia: concepts and controversies of an intraductal lesion of the breast. Pathology (2005) 0.91
Juxtaglomerular cell tumor: a morphological, immunohistochemical and genetic study of six cases. Hum Pathol (2012) 0.90
Validation of the Gail model for predicting individual breast cancer risk in a prospective nationwide study of 28,104 Singapore women. Breast Cancer Res (2012) 0.90
Hypericin-photodynamic therapy (PDT) using an alternative treatment regime suitable for multi-fraction PDT. J Photochem Photobiol B (2005) 0.89
BRCA1 and BRCA2 mutations in an Asian clinic-based population detected using a comprehensive strategy. Cancer Epidemiol Biomarkers Prev (2007) 0.88
Breast carcinoma in women 35 years and younger: a pathological study. Pathology (2006) 0.88
Casein kinase 1α-dependent feedback loop controls autophagy in RAS-driven cancers. J Clin Invest (2015) 0.87
Novel photodynamic diagnosis of bladder cancer: ex vivo fluorescence cytology using hypericin. Int J Oncol (2003) 0.87
GST-pi expression correlates with oxidative stress and apoptosis in breast cancer. Oncol Rep (2004) 0.87
Chronic exposure to U18666A induces apoptosis in cultured murine cortical neurons. Biochem Biophys Res Commun (2004) 0.87
Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle. Int J Oncol (2010) 0.87
Mucin extravasation in breast core biopsies--clinical significance and outcome correlation. Histopathology (2009) 0.87
Parkin enhances the expression of cyclin-dependent kinase 6 and negatively regulates the proliferation of breast cancer cells. J Biol Chem (2010) 0.87
Ductal carcinoma in situ within phyllodes tumour: a rare occurrence. Pathology (2005) 0.86
Cytokeratins in papillary lesions of the breast: is there a role in distinguishing intraductal papilloma from papillary ductal carcinoma in situ? Am J Surg Pathol (2005) 0.86
Breast cancer stem cells: an update. J Clin Pathol (2013) 0.86
Breast cancer in Singapore: some perspectives. Breast Cancer (2009) 0.86
Independent component analysis of dynamic contrast-enhanced magnetic resonance images of breast carcinoma: a feasibility study. J Magn Reson Imaging (2008) 0.85
Biopsy sampling of breast lesions: comparison of core needle- and vacuum-assisted breast biopsies. Breast Cancer Res Treat (2011) 0.85
Low-grade adenosquamous carcinoma of the breast. J Clin Pathol (2012) 0.85
Clinical validation of a customized multiple signature microarray for breast cancer. Clin Cancer Res (2008) 0.85
Live and lyophilized Lactobacillus species elicit differential immunomodulatory effects on immune cells. FEMS Microbiol Lett (2009) 0.84
Phyllodes tumours of the breast - differentiating features in core needle biopsy. Histopathology (2011) 0.84
Y-box binding protein 1 is correlated with lymph node metastasis in intestinal-type gastric cancer. Histopathology (2014) 0.84
CX3CL1 expression is associated with poor outcome in breast cancer patients. Breast Cancer Res Treat (2013) 0.84
A unique case of spontaneous regression of metastatic papillary renal cell carcinoma: a case report. Cases J (2009) 0.84
Intravascular lymphomatosis of the lung and liver following eyelid lymphoma in a Chinese man and review of primary pulmonary intravascular lymphomatosis. Pathology (2002) 0.84
HER2/neu revisited: quality and interpretive issues. J Clin Pathol (2010) 0.84
U18666A-mediated apoptosis in cultured murine cortical neurons: role of caspases, calpains and kinases. Cell Signal (2006) 0.83
Fluorescence detection of bladder cancer using urine cytology. Int J Oncol (2007) 0.83
Early detection of breast cancer through population-based mammographic screening in Asian women: a comparison study between screen-detected and symptomatic breast cancers. Breast J (2009) 0.83
Biomarkers in renal cancer. Virchows Arch (2014) 0.82
Over-expression of c-erbB-2 correlates with nuclear morphometry and prognosis in breast carcinoma in Asian women. Pathology (2006) 0.82
Symptomatic renal leiomyoma: report of two cases. Pathology (2006) 0.82